THE DECLASSIFIED
COLLECTION
← Browse the archive

Report of Inspection of MKULTRA — 2019 release package

1963-07-26 · 50 source pages

Original source record

The 2019 release package remains available at its source. An earlier release can be read here; the two releases have different page sets.

Source scans are unavailable here. Publisher annotations remain available below.

Publisher annotations

Commentary by The Declassified Collection, separate from the original source.

Source PDF page 5 · 2 notes

TS 185209/1 · Copy 1 of 1

A Top Secret control number and copy count. Beside it a later hand wrote Ser A cy 2 of 6: a copy series was made afterwards.

MKULTRA · MKDELTA

Two cryptonyms as the memorandum defines them: research and development, and the DD/P system controlling operational use.

Source PDF page 6 · 1 notes

J. S. Earman

John S. Earman, Inspector General. He also signs the memorandum of 29 November 1963 printed in Part III.

Source PDF page 7 · 1 notes

TSD, then TSS

One component under two names: the 1953 papers in Part II are signed TSS, and by 1963 the report calls it TSD.

Source PDF page 8 · 2 notes

Questions of legality

The four sensitivities are distinct: researchers' professional reputations, legality, the rights of U.S. citizens, and the consequences of public exposure. Keeping them separate matters when the report later weighs the intelligence value of unwitting tests against the risk of compromise.

Source PDF page 9 · 1 notes
Source PDF page 10 · 2 notes

radiation, electro-shock

Avenues added to the charter over ten years without a new authorisation. The recommendation is that the charter be redefined.

Source PDF page 11 · 1 notes

Minimum documentation

The next leaf explains the cost of this security practice: only two officers had full substantive knowledge, much of it unrecorded. Inspectors could not reconstruct a project's purpose, results and further requirements from its file. That weakness existed ten years before the drug-file destruction.

Source PDF page 12 · 1 notes

Two individuals

The inspectors identify a management bottleneck, not simply a small staff. Both officers applied 'need to know' even to colleagues and clerical assistants. Their personal knowledge substituted for records that senior managers and successors could independently examine.

Source PDF page 13 · 1 notes
Source PDF page 14 · 2 notes

sterile grants in aid

Research money passed through a cut-out, so the recipient need not know, or need not admit, where it came from.

witting

The Agency's term throughout these papers for someone who knows who is paying. Its opposite governs the final phase.

Source PDF page 15 · 2 notes

hospitals and prisons

The phase before the safehouses. The 1977 hearing returned to one such arrangement at Lexington, Kentucky.

Audit procedures waived

The report does not say the original waiver remained absolute. It describes later research contracts and secure funding systems, then proposes bringing the Deputy Director/Support into MKULTRA's administration. The audit dispute in Part II shows that scrutiny of safehouse spending was already possible in 1955.

Source PDF page 16 · 2 notes

Food and Drug Administration

Paragraph 9. The inspectors found no MKULTRA file showing how the programme would meet the new federal requirements.

unwitting subjects

The Agency's term for the final phase. The memoranda in Part II call the same thing covert and realistic field trials.

Source PDF page 17 · 2 notes
Source PDF page 18 · 2 notes

Scientific observation

The problem was more than the agents' qualifications. Subjects were usually unavailable after the first hours; illness could continue for days, with follow-up reduced to guarded inquiries. The inspectors distinguish observations useful for delivery techniques from the sustained observation needed to evaluate effects. The Church Committee later quoted this passage (The 1977 MKULTRA hearing — source PDF page 83).

operational value

What the Bureau got from the arrangement, in the report's own words. The exchange ran both ways.

Source PDF page 19 · 1 notes

the public press

Paragraph 15. The exposure risk, as assessed in 1963, was journalism rather than any inquiry.

Source PDF page 20 · 2 notes

No records

Admiral Turner read this sentence to the Senate in 1977 (The 1977 MKULTRA hearing — source PDF page 13). It identifies a gap in approval records, not an absence of every kind of paper: the safehouse funding, inventory and audit documents in Part II are the surviving counterpoint.

No effective cover story

TSD claimed to transfer responsibility to the Bureau of Narcotics, yet expected the Bureau's chief to deny knowledge. The inspector then follows responsibility down to the narcotics agent working alone, with no planning-and-approval record and a risk that critical results would never reach senior management.

Source PDF page 21 · 2 notes

testing on foreign nationals

Paragraph 19, immediately after the recommendation to stop testing on Americans. The report treats the two as separable.

correctly attribute the cause

The risk as framed here is not harm to the subject but the subject working out what had happened.

Source PDF page 22 · 1 notes

Dr. Sidney Gottlieb

Deputy Chief of TSD, and author of a 1960 study of the programme. His is the only name the folders in Part II leave unboxed.

Source PDF page 23 · 2 notes

no knockout pill

The 1960 assessment: no truth serum, aphrodisiac or recruitment pill was known to exist either.

high-risk, low-yield

The programme's own description of MKDELTA as a field of operations, three years before this inspection.

Source PDF page 24 · 1 notes

unilateral operations

Operations run without a partner service's knowledge. The argument that testing abroad was impracticable kept it at home.

Source PDF page 25 · 2 notes

TDY visits

Temporary duty. The paragraph treats such visits as a way of advertising the capability to officers not using it.

Chief, Medical Staff

Medical consultation was available but not the final approval gate. The DD/P could consult the Chief about medical risk; the report explicitly says the Chief would not expect to have final authority to disapprove an operation. The operational chain retained that decision.

Source PDF page 26 · 2 notes

basic moral objections

Some case officers refused to use the materials. The objection is recorded as an obstacle to be managed.

CI Staff study

A 1960 recommendation the inspection notes had not been acted on. It is repeated on the next leaf.

Source PDF page 27 · 1 notes

144 projects · twenty-five

The programme's size in the inspector's count, and the number still running. Subproject numbering later reached 149.

Source PDF page 28 · 1 notes

petroleum sabotage

One of the miscellaneous projects in the inspection's own classification, with defoliants and remote measurement.

Source PDF page 29 · 1 notes

Oral communication

The inspectors feared loss through turnover as well as missing paperwork: much of the programme's record rested in officers' memories. Turner later identified both sparse original records and the destruction of 1973 when explaining the gaps to Congress (The 1977 MKULTRA hearing — source PDF page 13).

Source PDF page 30 · 2 notes

added in 1962 under pressure

The support officer arrived nine years into the programme, and one year before this inspection.

re-confirmation of authority

The first recommendation: go back to the Director and rewrite the 1953 charter, which is bound in at Tab A.

Source PDF page 31 · 1 notes

Deputy Director/Research

A separate directorate created in 1962. The recommendation would have made MKULTRA coordinate with it.

Source PDF page 32 · 2 notes

Accredited institutions

Recommendation (g) would remove testing from the safehouse arrangement by requiring accredited institutions and accepted scientific procedures. The November meeting reopened the question of unwitting tests; its conditional route to the Director is at MKULTRA: debate over unwitting drug tests — source PDF page 2.

HR 31-1

The Agency's own audit regulation. The last recommendation asks only that MKULTRA be audited under it.

Source PDF page 34 · 2 notes

Richard Helms

Acting Deputy Director (Plans), signing the request that created MKULTRA. He appears twice more in this volume.

Five controlled copies

These are the 1953 papers requesting authority for MKULTRA, not authorization of the 1963 inspection. The controlled set contains the description of the research programme at Tab A and a proposed payment authority at Tab B.

Source PDF page 35 · 1 notes

Tab A

The divider introduces the founding programme description. Its control number and copy mark identify it as part of the five-copy authorization set, even when separated from the adjoining text.

Source PDF page 36 · 1 notes

Project Review Committee

The body that approved the research programme in June 1952. MKULTRA was carved out of a budget already passed.

Source PDF page 37 · 1 notes

Contracts and concealment

The paper gives two reasons to avoid ordinary contracts: a written agreement would reveal government interest, and some cleared researchers feared damage to their professional reputations. The proposed substitute was internal approval and certification, while an intermediary could stand between researcher and Agency.

Source PDF page 38 · 2 notes

the cut-out

An intermediary, so the researcher deals with someone other than the Agency.

Source PDF page 39 · 1 notes

Government sterility

The formal object of the arrangement, to be settled with the Inspection & Security Office.

Source PDF page 40 · 1 notes

Monthly financial report

The special procedure still promised monthly information on commitments, spending and the balance remaining. The founding papers therefore did not dispense with all financial reporting; they concentrated detailed project knowledge inside TSS.

Source PDF page 41 · 1 notes

TAB B

The second tab: the Director's authority of 13 April 1953, the memorandum for the file, and the 1960 MKDELTA instruction.

Source PDF page 42 · 1 notes
Source PDF page 43 · 2 notes

/s/ ALLEN W. DULLES

A conformed /s/ notation, not Dulles's autograph: this is the file copy.

no further documents

The sentence that made the three certifications sufficient, in the Director's own memorandum.

Source PDF page 44 · 2 notes

a separate file per subproject

The rule that produced the folders in Part II. Subprojects 3, 16 and 42 are three such files.

the blank signature blocks

Ruled and empty on this file copy. The memorandum prescribes a form; these blank blocks do not record its execution.

Source PDF page 45 · 1 notes

The Comptroller’s copy

The invoice goes to the Comptroller, but substantive project records remain with TSS. This separates the evidence authorizing a payment from the fuller account of what the project is meant to do.

Source PDF page 46 · 1 notes

Three certifications

Three officers attest to different things: the Division Chief to satisfactory work and an unpaid, correct bill; the Research Director to approval and authorized payment; the Research Board's secretary to the programme's approved scope. These are prescribed forms, not three signatures certifying this particular blank page.

Source PDF page 47 · 3 notes

K and L tablets

Named in the 22 July 1960 instruction, one of four leaves absent from the earlier release. They are not explained on the page.

To Leo for file

Read as To Leo for file; for file is clear and the short name is less distinct. A handwritten routing note at the head of the instruction.

Rescission

This instruction replaces an earlier one of 20 October 1952, whose reference is withheld.

Source PDF page 48 · 1 notes

RICHARD M. BISSELL, JR.

The name is typed. There is no autograph, no /s/ and no withholding box above it: a typed name over a title.

Source PDF page 50 · 2 notes

The funding columns

The table preserves the MKULTRA percentages even where an amount is withheld. The 1962 total also has unreadable leading digits. The fully readable 1960 and 1961 rows show the table's structure: research programme plus MKULTRA equals the total, with MKULTRA expressed as a share of that total.

Through 8 May 1963

The table stops eleven weeks before the report is signed. It is the last leaf of the 2019 release.